Penumbra (PEN) Cash & Current Investments (2014 - 2026)
Penumbra (PEN) reported Cash & Current Investments of $615.7 million for Q1 2026, up 62.51% year-over-year from $378.8 million in Q1 2025, and up 13.0% on a QoQ basis from $544.8 million in Q4 2025.
Penumbra (PEN) has 13 years of Cash & Current Investments data on file, last reported at $615.7 million in Q1 2026.
- Quarterly Cash & Current Investments rose 62.51% year-over-year to $615.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $615.7 million (up 62.51% YoY) and the FY2025 annual result came in at $544.8 million, up 60.18% from the prior year.
- Cash & Current Investments improved to $615.7 million in Q1 2026 per PEN's latest filing, from $544.8 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $615.7 million in Q1 2026 and bottomed at $184.4 million in Q3 2022.
- The 5-year median for Cash & Current Investments is $291.0 million (2024), against an average of $323.2 million.
- The widest annual swing landed in 2022, when Cash & Current Investments plunged 30.91%; it then soared 62.51% in 2026.
- Tracing PEN's Cash & Current Investments over 5 years: stood at $188.0 million in 2022, then soared by 53.8% to $289.2 million in 2023, then increased by 17.62% to $340.1 million in 2024, then jumped by 60.18% to $544.8 million in 2025, then increased by 13.0% to $615.7 million in 2026.
- Per Business Quant, the three latest PEN Cash & Current Investments figures stand at $615.7 million (Q1 2026), $544.8 million (Q4 2025), and $470.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn | 615.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 615.66 Mn |
| Dec 31, 2025 | 544.82 Mn |
| Sep 30, 2025 | 470.30 Mn |
| Jun 30, 2025 | 424.56 Mn |
| Mar 31, 2025 | 378.85 Mn |
| Dec 31, 2024 | 340.13 Mn |
| Sep 30, 2024 | 291.02 Mn |
| Jun 30, 2024 | 339.70 Mn |
| Mar 31, 2024 | 313.47 Mn |
| Dec 31, 2023 | 289.19 Mn |
| Sep 30, 2023 | 248.86 Mn |
| Jun 30, 2023 | 221.06 Mn |
| Mar 31, 2023 | 199.10 Mn |
| Dec 31, 2022 | 188.03 Mn |
| Sep 30, 2022 | 184.43 Mn |
| Jun 30, 2022 | 204.37 Mn |
| Mar 31, 2022 | 240.34 Mn |
| Dec 31, 2021 | 254.88 Mn |
| Sep 30, 2021 | 266.93 Mn |
| Jun 30, 2021 | 156.72 Mn |
| Mar 31, 2021 | 242.61 Mn |
| Dec 31, 2020 | 264.83 Mn |
| Sep 30, 2020 | 268.73 Mn |
| Jun 30, 2020 | 278.30 Mn |
| Mar 31, 2020 | 168.22 Mn |
| Dec 31, 2019 | 189.39 Mn |
| Sep 30, 2019 | 194.45 Mn |
| Jun 30, 2019 | 187.26 Mn |
| Mar 31, 2019 | 167.09 Mn |
| Dec 31, 2018 | 200.89 Mn |
| Sep 30, 2018 | 193.92 Mn |
| Jun 30, 2018 | 206.89 Mn |
| Mar 31, 2018 | 213.27 Mn |
| Dec 31, 2017 | 214.59 Mn |
| Sep 30, 2017 | 218.82 Mn |
| Jun 30, 2017 | 218.64 Mn |
| Mar 31, 2017 | 231.64 Mn |
| Dec 31, 2016 | 128.75 Mn |
| Sep 30, 2016 | 141.83 Mn |
| Jun 30, 2016 | 139.86 Mn |
| Mar 31, 2016 | 144.42 Mn |
| Dec 31, 2015 | 148.80 Mn |
| Sep 30, 2015 | 159.10 Mn |
| Jun 30, 2015 | 36.76 Mn |
| Mar 31, 2015 | 8.13 Mn |
| Dec 31, 2014 | 51.54 Mn |
| Sep 30, 2014 | 8.19 Mn |